Download FREE Report Sample
Download Free sampleDextrose 50% For Injection is a sterile, nonpyrogenic hypertonic solution of dextrose in water for injection for intravenous injection as a fluid and nutrient replenisher.The explosion of COVID-19 around the world has led to a huge increase in the demand for this solution.
50% Dextrose Injection Market contains market size and forecasts of 50% Dextrose Injection in global, including the following market information:
Global 50% Dextrose Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 50% Dextrose Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 50% Dextrose Injection companies in 2021 (%)
The global 50% Dextrose Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
20ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 50% Dextrose Injection include Amphastar, Pfizer, Abbott, Baxter, Cisen Pharmaceutical, Medisan and Tafong Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the 50% Dextrose Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 50% Dextrose Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 50% Dextrose Injection Market Segment Percentages, by Type, 2021 (%)
20ml
40ml
50ml
Global 50% Dextrose Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 50% Dextrose Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Recovery Center
Global 50% Dextrose Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 50% Dextrose Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 50% Dextrose Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 50% Dextrose Injection revenues share in global market, 2021 (%)
Key companies 50% Dextrose Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 50% Dextrose Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amphastar
Pfizer
Abbott
Baxter
Cisen Pharmaceutical
Medisan
Tafong Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy